FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and medicine and represents an agent possessing neuroprotective action in ischemic cerebral circulation disorder, characterised by that it includes 4-amino-3-phenyl butanoic acid, L-arginine hydrochloride, molar ratio of 4-amino-3-phenyl butanoic acid and said L-arginine hydrochloride is 1:2.
EFFECT: invention widens range of low-toxic agents possessing neuroprotective action in ischemic cerebral circulation disorder.
1 cl, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
| NEW WATER-SOLUBLE SALICYLAMIDE DERIVATIVE WITH NEUROPROTECTIVE ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2017 |
|
RU2641102C1 |
| N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| 4-(4-ACETOXYBENZOYLAMINO)BUTANOYLGLYCINE, WHICH HAS A CEREBROPROTECTIVE ACTION IN CEREBRAL ISCHEMIA | 2017 |
|
RU2657820C1 |
